Department of Clinical Pharmacology and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University Erlangen-Nuremberg, Germany.
Drug Metab Rev. 2010 Aug;42(3):380-401. doi: 10.3109/03602530903491683.
Uptake transporters in the basolateral membrane of hepatocytes are important for the hepatobiliary elimination of drugs. Further, since drug-metabolizing enzymes are located intracellularly, uptake into hepatocytes is a prerequisite for their subsequent metabolism. Therefore, alteration of uptake transporter function (e.g., by concomitantly administered drugs or due to functional consequences of genetic variations, leading to reduced transport function) may result in a change in drug pharmacokinetics. In this review, we focus on the hepatocellularly expressed members of the OATP and OCT family, their impact on transport-mediated drug-drug interactions, and on the functional consequences of variations in genes encoding these transporters.
肝细胞基底外侧膜中的摄取转运体对于药物的肝胆消除非常重要。此外,由于药物代谢酶位于细胞内,因此摄取进入肝细胞是其随后代谢的前提。因此,摄取转运体功能的改变(例如,由于同时给予的药物或由于遗传变异的功能后果导致转运功能降低)可能导致药物药代动力学的变化。在本综述中,我们重点介绍了 OATP 和 OCT 家族中在肝细胞中表达的成员,它们对转运介导的药物相互作用的影响,以及编码这些转运体的基因变异的功能后果。